Background Anticholinergic medications such as ipratropium improve the pulmonary
function of patients with acute exacerbations of asthma, but their effect on hospitalization …

Objective: The objective of this trial was to determine the efficacy of frequent nebulized
ipratropium added to high-dose albuterol therapy in children with severe asthma. Methods …

Objective To determine whether the addition of inhaled ipratropium bromide to inhaled
albuterol and systemic corticosteroid therapy was more efficacious than inhaled albuterol …

Objective: To determine whether the addition of repeated doses of nebulized ipratropium
bromide (IB) to a standardized inpatient asthma care algorithm (ACA) for children with status …

Objective. To determine if the addition of ipratropium bromide to the emergency department
(ED) treatment of childhood asthma reduces time to discharge, number of nebulizer …

Study objective: To determine the effect of adding the nebulized anticholinergic drug
ipratropium bromide to standard therapy compared with standard therapy alone for acute …

Ipratropium bromide is a quaternary anticholinergic bronchodilator that is commonly used to
treat obstructive lung disease. Although ipratropium is not usually employed as a first-line …

Purpose: To review the literature to determine whether inhaled ipratropium bromide
provides additive benefits to adults with acute asthma who are being treated with beta …

Purpose: To determine whether inhaled ipratropium bromide provides an additive, clinically
important improvement in children with acute asthma who are being treated with β2 …

Nebulized ipratropium bromide is thought to be synergistic with albuterol in therapy for acute
childhood asthma. Because the efficacy of ipratropium in bronchiolitis is uncertain and some …